Literature DB >> 3274336

In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.

R J Tesi1, J Hong, K M Butt, B M Jaffe, M A McMillen.   

Abstract

We have shown that the addition of verapamil, a calcium channel blocking agent, or trifluoperazine, a phenothiazine, to a regiment using the immunosuppressive agent Cs significantly enhances heterotopic cardiac allograft survival in an ACI to Lewis transplant model. This work verifies previous in vitro work from our laboratory and offers a potential therapeutic strategy to decrease the dose of Cs needed for effective immunosuppression while perhaps lessening its dose-related side effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3274336

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Clinical studies of human islet transplantation.

Authors:  N J London
Journal:  Ann R Coll Surg Engl       Date:  1995-07       Impact factor: 1.891

2.  Novel mode of action of the calcium antagonist mibefradil (Ro 40-5967): potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium.

Authors:  R A Blaheta; N P Hailer; N Brude; B Wittig; E Oppermann; K Leckel; S Harder; M Scholz; S Weber; A Encke; B H Markus
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.